Variant report
Variant | nsv5075 |
---|---|
Chromosome Location | chr5:152644472-152679211 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534627755 | chr5:152644519-152644520 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs538593317 | chr5:152644638-152644639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs1350900 | chr5:152644679-152644680 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
4 | rs571266077 | chr5:152644686-152644687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs538595967 | chr5:152644687-152644688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs138344008 | chr5:152644716-152644717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs143838350 | chr5:152644752-152644753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs537677614 | chr5:152644807-152644808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs371437941 | chr5:152644812-152644813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs142945098 | chr5:152644831-152644832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs555668636 | chr5:152644839-152644840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs373378617 | chr5:152644840-152644841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs181408076 | chr5:152644890-152644891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs559574088 | chr5:152644951-152644952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs186551191 | chr5:152644962-152644963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs577626510 | chr5:152645045-152645046 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs544994172 | chr5:152645102-152645103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs147261817 | chr5:152645122-152645123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs530888440 | chr5:152645157-152645158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs192041327 | chr5:152645158-152645159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs560948015 | chr5:152645165-152645166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs117182254 | chr5:152645171-152645172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs982494 | chr5:152645213-152645214 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs570711000 | chr5:152645275-152645276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs538683202 | chr5:152645306-152645307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs550570358 | chr5:152645349-152645350 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs552473563 | chr5:152645374-152645375 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs2927172 | chr5:152645390-152645391 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs2973149 | chr5:152645408-152645409 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs535982454 | chr5:152645421-152645422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs73274195 | chr5:152645440-152645441 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs574157091 | chr5:152645492-152645493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs534850199 | chr5:152645493-152645494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs148748379 | chr5:152645509-152645510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs77162183 | chr5:152645526-152645527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs545028649 | chr5:152645527-152645528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs141508030 | chr5:152645552-152645553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs575566734 | chr5:152645594-152645595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs542757005 | chr5:152645612-152645613 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs183315694 | chr5:152645690-152645691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563160823 | chr5:152645697-152645698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs528333498 | chr5:152645759-152645760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs2964817 | chr5:152645765-152645766 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs369871868 | chr5:152645834-152645835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs565203685 | chr5:152645847-152645848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs186524659 | chr5:152645849-152645850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs550862109 | chr5:152645885-152645886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs373490903 | chr5:152645912-152645913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs568785671 | chr5:152645974-152645975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs191119611 | chr5:152646006-152646007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Breast cancer | 17603634 | CNVD |
Crohn''s disease | 20106866 | CNVD |
Breast cancer | 20409316 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Deafness | 19353646 | CNVD |
Developmental delay | 19353646 | CNVD |
dysmorphism | 19353646 | CNVD |
feeding difficulties | 19353646 | CNVD |
strabismus | 19353646 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:152643200-152647000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr5:152646400-152647000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr5:152646600-152648400 | Enhancers | NHEK | skin |
4 | chr5:152646800-152647000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr5:152646800-152648400 | Enhancers | HMEC | breast |
6 | chr5:152647000-152648000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
7 | chr5:152647000-152648200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr5:152648000-152648600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
9 | chr5:152679000-152679400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |